Adamis Pharmaceuticals

Novartis amps up Symjepi launch to fill Pfizer's EpiPen supply gap
Novartis amps up Symjepi launch to fill Pfizer's EpiPen supply gap
Fierce Pharma
Novartis
Mylan
Pfizer
EpiPens
Sandoz
Symjepi
drug launches
Adamis Pharmaceuticals
Flag link:
Rival accuses Kaleo of cybersquatting in 'elaborate scheme'
Rival accuses Kaleo of cybersquatting in 'elaborate scheme'
Biopharma Dive
Kaleo
Auvi-Q
Adamis Pharmaceuticals
Symjepi
cybersquatting
Flag link:
FDA hands back Adamis' application for an ED drug, looking for more data
FDA hands back Adamis' application for an ED drug, looking for more data
Endpoints
Adamis Pharmaceuticals
erectile dysfunction
tadalafil
FDA
Flag link:
Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates
Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
biotech
FDA
Roche
Tecentriq
GSK
mepolizumab
Teva Pharmaceutical
fremanezumab
Adamis Pharmaceuticals
Symjepi
Insmed
ALIS
Antares
XYOSTED
Eli Lilly
galcanezumab
Pfizer
dacomitinib
Flag link:
Novartis steps in to compete with Mylan’s Epipen
Novartis steps in to compete with Mylan’s Epipen
Drug Delivery Business News
Adamis Pharmaceuticals
Novartis
Sandoz
Symjepi
Mylan
EpiPens
Flag link:
EpiPen alternative Symjepi gets FDA OK
EpiPen alternative Symjepi gets FDA OK
BioPharma Dive
EpiPens
Mylan Labs
Symjepi
Adamis Pharmaceuticals
FDA
Flag link:
Who stands to benefit from Mylan's EpiPen recall?
Who stands to benefit from Mylan's EpiPen recall?
BioPharma Dive
Mylan Labs
EpiPens
recalls
Adamis Pharmaceuticals
Kaleo
Impax Labs
Flag link:
EpiPen rivals inch towards market
EpiPen rivals inch towards market
BioPharma Dive
EpiPens
Mylan Labs
Kaleo
Auvi-Q
Adamis Pharmaceuticals
Flag link:
Specialty pharma working to bring EpiPen competitor to market
Specialty pharma working to bring EpiPen competitor to market
BioPharma Dive
EpiPen
drug pricing
Mylan Labs
Adamis Pharmaceuticals
Flag link:
Can anyone shake the EpiPen monopoly? Here’s one company that’s tryi
Can anyone shake the EpiPen monopoly? Here’s one company that’s tryi
Stat
EpiPen
Mylan Labs
Sanofi
Adamis Pharmaceuticals
Flag link:
7 Biopharma Companies That Destroyed Shareholders Last Week
7 Biopharma Companies That Destroyed Shareholders Last Week
24/7 Wall St
ProNai
Adamis Pharmaceuticals
Ocular Therapeutics
Mirati Therapeutics
Immunomedics
Valeant Pharmacueticals
Biogen
Flag link:
FDA rejects Adamis Pharma's injection for treating allergic reactions
FDA rejects Adamis Pharma's injection for treating allergic reactions
Yahoo/Reuters
FDA
Adamis Pharmaceuticals
epinephrine
Flag link:
Adamis Pharmaceuticals Corp. (ADMP) is “One to Watch”
Adamis Pharmaceuticals Corp. (ADMP) is “One to Watch”
Beacon Equity Research
Adamis Pharmaceuticals
TeloB-VAX
prostate cancer
cancer vaccines
Flag link:
La Jolla Pharmaceutical, Adamis Pharmaceuticals to terminate merger agreement
La Jolla Pharmaceutical, Adamis Pharmaceuticals to terminate merger agreement
The Medical News
La Jolla Pharmaceutical
Adamis Pharmaceuticals
Flag link:
Adamis Pharma signs pact to acquire prostate cancer drug candidates from Colby Pharma
Adamis Pharma signs pact to acquire prostate cancer drug candidates from Colby Pharma
Pharmabiz
Adamis Pharmaceuticals
prostate cancer
Flag link:
La Jolla Pharmaceutical Company Provides Responses to Frequently Asked Questions about Merger Vote
La Jolla Pharmaceutical Company Provides Responses to Frequently Asked Questions about Merger Vote
Yahoo/BusinessWire
La Jolla Pharmaceutical
Adamis Pharmaceuticals
M&A
Flag link: